Ratnakar Securities Pvt. Ltd.

ORCHID PHARMA LTD.

NSE : ORCHPHARMABSE : 524372ISIN CODE : INE191A01027Industry : Pharmaceuticals & DrugsHouse : Private

BSE710.00-2.4 (-0.34 %)

PREV CLOSE ( ) 712.40

OPEN PRICE ( ) 712.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4914

TODAY'S LOW / HIGH ( )703.00 713.80

52 WK LOW / HIGH ( )603.8 1998

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-07 1992

Management Info

Ram Gopal Agarwal - Chairman Manish Dhanuka - Managing Director

Registered Office

Address Plot Nos. 121-128, 128 A-133, 138-151, 159-164,Sidco Industrial Estate,Alathur,
Chengalpattu,
Tamil Nadu-603110

Phone 044-44-2744 4471/72/73

Email corporate@orchidpharma.com / nikitak@orchidpharma.com

Website www.orchidpharma.com

Registrars Details

Abhipra Capital Ltd

Abhipra Complex,A-387 Azadpur,Dilkush Indl.Area G T Karnal Road ,New Delhi

Listing : BSE, NSE

NEWS

18Jul Orchid Pharma executes Deed of Hypothe
Orchid Pharma has executed a Deed of Hypothecation for securing various..

20Feb USFDA concludes inspection at API manu
U.S. Food and Drug Administration (USFDA) has concluded the inspection a..

12Nov Orchid Pharma informs about newspaper
In accordance to Regulation 47 of Securities and Exchange Board of India..

07Aug Orchid Pharma submits analyst meet int
Orchid Pharma has informed that pursuant to Regulation 30 read with Para..

01Jul Orchid Pharma gains on partnering with
Orchid Pharma is currently trading at Rs. 1150.35, up by 10.50 points or..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	278.5	1064.84
Gross Profit	278.5	1064.84
Operating Profit	405.92	1554.6
Net Sales	2374.79	9219.26

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE) 3602.50 (2.46%)	M.Cap ( in Cr)121924.97
Pfizer (BSE) 5354.75 (1.23%)	M.Cap ( in Cr)24496.77
Cipla (BSE) 1531.10 (2.95%)	M.Cap ( in Cr)123674.79
Solara Active Pharma (BSE) 695.80 (5.85%)	M.Cap ( in Cr)3350.49
Alkem Laboratories (BSE) 5018.45 (0.41%)	M.Cap ( in Cr)60003.10

Shareholding Pattern

	NON-INSTITUTION	9.34%
	PROMOTERS	69.84%
	MUTUAL FUNDS/UTI	18.58%
	FI/BANKS/INSURANCE	0.2%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Kotak Healthcare Fu...	1.58
Kotak Consumption F...	1.42
Kotak Special Oppor...	1.34
ITI Pharma & Health...	1.13
Quant Small Cap Fund(G)	0.84
PGIM India Healthca...	0.75

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

ORCHID PHARMA LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES